• $87.00
    Market Cap
  • 0.00%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2021
12/31/2020
Income Statement
Total Operating Revenue
6,417
N/A
0
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
Gross Profit
6,417
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
Research and Development Expense
-3.2M
-22.47%
-4.1M
N/A
Depreciation and Amortization Expense
9,368
+255.79%
2,633
N/A
Total Operating Expenses
5.4M
-44.10%
9.7M
N/A
Operating Profit
-5.4M
-44.10%
-9.7M
N/A
Interest Income
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
Total Nonoperating Income and Expense
937,693
+628.24%
128,762
N/A
Income before Taxes
-5.4M
-44.10%
-9.7M
N/A
Income Taxes
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
-4.5M
-53.17%
-9.5M
N/A
Net Income from Continuing Operations Applicable to Common
-4.5M
-53.17%
-9.5M
N/A
Basic EPS and Net Income
N/A
N/A
-0.11
N/A
Diluted EPS and Net Income
N/A
N/A
-0.11
N/A
Basic Weighted Average Shares
87.4M
0.00%
87.4M
N/A
Diluted Weighted Average Shares
N/A
N/A
87.4M
N/A
Balance Sheet
Cash and Cash Equivalents
2.8M
-61.56%
7.4M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
2.8M
-61.56%
7.4M
N/A
Total Current Assets
3.4M
-57.61%
8.0M
N/A
Accumulated Depreciation
12,952
N/A
N/A
N/A
Property and Plant and Equipment and Net
29,271
-24.25%
38,640
N/A
Total Long-Term Assets
50,747
-63.16%
137,749
N/A
Total Assets
3.7M
-56.50%
8.4M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
50,000
0.00%
50,000
N/A
Total Current Liabilities
1.3M
+1.29%
1.3M
N/A
Total Long-Term Debt
800,000
N/A
N/A
N/A
Total Long-Term Liabilities
30,497
+6.61%
28,607
N/A
Total Liabilities
1.3M
-0.91%
1.3M
N/A
Retained Earnings
-34.2M
+15.02%
-29.8M
N/A
Total Stockholders Equity
2.3M
-66.85%
7.1M
N/A
Total Shares Outstanding
87.4M
0.00%
87.4M
N/A
Cash Flow
Cash from Operating Activities
-4.6M
-3.37%
-4.7M
N/A
Capital Expenditures
N/A
N/A
41,273
N/A
Cash from Investing Activities
N/A
N/A
-49,268
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
N/A
N/A
N/A
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
Operating Margin
-84,298.21%
N/A
N/A
N/A
Return on Assets
-74.23%
-19.01%
-91.65%
N/A
Return on Equity
-94.88%
-4.41%
-99.26%
N/A
Revenue Growth
N/A
N/A
-100.00%
N/A
Current Ratio
2.59
-58.15%
6.19
N/A
Cash Ratio
2.18
-62.06%
5.75
N/A
Debt-to-Equity Ratio
0.36
N/A
N/A
N/A
Debt-to-Assets Ratio
0.23
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow